Pfizer signs deal with Allogene to develop cancer cell therapy – Reuters
|
Pfizer signs deal with Allogene to develop cancer cell therapy
Reuters San Francisco-based Allogene specializes in cancer treatment by developing CAR T cell therapy for blood cancer and tumors. Servier and Allogene aim to start mid-stage studies in 2019 with Allogene having the exclusive rights to develop and … |
